180 related articles for article (PubMed ID: 9761285)
1. Angiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists.
Dubey RK; Flammer J; Lüscher TF
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2067-75. PubMed ID: 9761285
[TBL] [Abstract][Full Text] [Related]
2. Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists.
Meyer P; Flammer J; Lüscher TF
Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):555-62. PubMed ID: 7890486
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle.
Sung CP; Arleth AJ; Storer BL; Ohlstein EH
J Pharmacol Exp Ther; 1994 Oct; 271(1):429-37. PubMed ID: 7965744
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells.
Briand V; Riva L; Galzin AM
Br J Pharmacol; 1994 Aug; 112(4):1195-201. PubMed ID: 7952881
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors.
Dubey RK; Jackson EK; Lüscher TF
J Clin Invest; 1995 Jul; 96(1):141-9. PubMed ID: 7615784
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells.
Chiu AT; Roscoe WA; McCall DE; Timmermans PB
Receptor; 1991; 1(3):133-40. PubMed ID: 1843203
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
8. Valsartan inhibits angiotensin II-stimulated proliferation of smooth muscle cells from human coronary artery.
Mueck AO; Seeger H; Lippert TH
Int J Clin Pharmacol Ther; 1999 Jul; 37(7):365-6. PubMed ID: 10442512
[TBL] [Abstract][Full Text] [Related]
9. Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells.
Koh E; Morimoto S; Tomita J; Rakugi H; Jiang B; Inoue T; Nabata T; Fukuo K; Ogihara T
J Cardiovasc Pharmacol; 1994 Feb; 23(2):175-9. PubMed ID: 7511744
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S
Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485
[TBL] [Abstract][Full Text] [Related]
11. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T
J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748
[TBL] [Abstract][Full Text] [Related]
12. Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells.
Dubey RK
J Pharmacol Exp Ther; 1994 Apr; 269(1):402-8. PubMed ID: 8169847
[TBL] [Abstract][Full Text] [Related]
13. Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury.
Nozawa Y; Matsuura N; Miyake H; Yamada S; Kimura R
Life Sci; 1999; 64(22):2061-70. PubMed ID: 10374931
[TBL] [Abstract][Full Text] [Related]
14. Characterization of PD 121981- and CGP 42112-induced unmasking of low concentration effects of angiotensin II in rabbit abdominal aorta.
Hong KW; Rhim BY; Shin YW; Yoo SE
J Pharmacol Exp Ther; 1994 Dec; 271(3):1591-6. PubMed ID: 7996473
[TBL] [Abstract][Full Text] [Related]
15. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells.
Hu ZW; Kerb R; Shi XY; Wei-Lavery T; Hoffman BB
J Pharmacol Exp Ther; 2002 Nov; 303(2):563-73. PubMed ID: 12388637
[TBL] [Abstract][Full Text] [Related]
17. Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.
Iouzalen L; Stepien O; Marche P
J Pharmacol Exp Ther; 1999 Apr; 289(1):181-7. PubMed ID: 10087002
[TBL] [Abstract][Full Text] [Related]
18. The angiotensin type 2 receptor mediates RNA synthesis in A10 vascular smooth muscle cells.
Saward L; Zahradka P
J Mol Cell Cardiol; 1996 Mar; 28(3):499-506. PubMed ID: 9011633
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effects of m-nifedipine on angiotensin II stimulated proliferation and protein synthesis in cultured rabbit aortic smooth muscle cells].
Gu HB; Tang YH; Xu Y
Yao Xue Xue Bao; 1996; 31(10):732-6. PubMed ID: 9863239
[TBL] [Abstract][Full Text] [Related]
20. Effects of valsartan on angiotensin II-induced migration of human coronary artery smooth muscle cells.
Kohno M; Ohmori K; Nozaki S; Mizushige K; Yasunari K; Kano H; Minami M; Yoshikawa J
Hypertens Res; 2000 Nov; 23(6):677-81. PubMed ID: 11131281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
